Telsey Advisory raised the firm’s price target on Bath & Body Works to $25 from $23 and keeps a Market Perform rating on the shares. The firm is encouraged by the company’s Q4 performance, noting results were better than expected, the analyst tells investors. The firm believes the company remains an established brand, but continues to expect topline and operating margin pressure in 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works price target raised to $23 from $22 at Deutsche Bank
- Bath & Body Works price target raised to $26 from $17 at Goldman Sachs
- Bath & Body Works price target lowered to $22 from $23 at JPMorgan
- Bath & Body Works price target raised to $25 from $21 at Barclays
- Bath & Body Works Charts Turnaround Amid 2026 Squeeze